Brain metastases

Current Problems in Surgery

Volumn 41, Issue 8, 2004, Pages 665-741

  Shaffrey, M E ^a   Mut, M ^a   Asher, A L ^a   Burri, S H ^a   Chahlavi, A ^a   Chang, S M ^a   Farace, E ^a   Fiveash, J B ^a   Hentschel, S J ^a   Lang, F F ^a   Lope, M B S ^a   Markert, J M ^a   Shiff, D ^a   Siomin, V ^a   Tatter, S B ^a   Vogelbaum, M A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CARBAMAZEPINE; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETIRACETAM; ETOPOSIDE; FLUOROURACIL; FOTEMUSTINE; GEFITINIB; IDARUBICIN; IRINOTECAN; LOMUSTINE; LORAZEPAM; MEGESTROL ACETATE; NITROSOUREA DERIVATIVE; PACLITAXEL; PHENOBARBITAL; PHENYTOIN; TAMOXIFEN; TEMOZOLOMIDE; TENIPOSIDE; THIOTEPA; TOPOTECAN; TRASTUZUMAB; UNINDEXED DRUG; VALPROIC ACID; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR;

BEAM THERAPY; BRAIN METASTASIS; BRAIN RADIATION; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED SURGERY; COPING BEHAVIOR; DEPRESSION; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG PENETRATION; EPILEPTIC STATE; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; MELANOMA; MOLECULAR BIOLOGY; NEUROIMAGING; NONHUMAN; PATIENT CARE; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION; RADIOSURGERY; REVIEW; SKIN TOXICITY; SOCIAL SUPPORT; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE; UROGENITAL TRACT CANCER; VISCERAL METASTASIS; WORK RESUMPTION; BRAIN TUMOR; DRUG ANTAGONISM; METASTASIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; QUALITY OF LIFE; RADIOSURGERY; RADIOTHERAPY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURGERY, COMPUTER-ASSISTED;

EID: 4944238383     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2004.06.001     Document Type: Article

References (262)

1. Cancer Society 2002, http://www.cancer.org/downloads/STT/CancerFacts&Figures2002TM.pd July 31, 2004.
2. Landis S.H. Murray T. Bolden S. Wingo P.A. Canser statistic, 1998. CA Cancer, 1998. J Clin 1998 48 6-29
3. Chang L. Sakamoto G.T. Brown N.P. Adler J.R. Stereotactic radiosurgery in patients with multiple brain metastases. Neuro Focus 2000 9 2
4. J.B. Posner Management of brain metastases Rev Neurol 148 1992 477-487
5. P.Y. Wen J.S. Loeffler Management of Brain Metastases Oncology (Huntingt) 13 1999 941-957
6. J.S. Nelson A. von Deimling I. Petersen R.-C. Janzer Metastatic tumours of the CNS : World Health Organization classification of tumours In: P. Kleihues W.K. Cavenee (Eds.) Pathology and genetics of tumours of the nervous system 2000 IARC Press Lyon 250-253
7. R. Sawaya B.L. Ligon R.K. Bindal Management of metastatic brain tumors Ann Surg Oncol 1 1994 169-178
8. R. Sawaya R.K. Bindal F.F. Lang D. Abi-Said Metastatic brain tumors In: A.H. Kaye E.R. Jr Laws (Eds.) Brain Tumors: An Encyclopedic Approach 2nd ed 2001 Churchill Livingston New York 999-991026
9. S.D. Lavine Z. Petrovich A.A Cohen-Gadol Gamma knife radiosurgery for metastatic melanoma: An analysis of survival, outcome, and complications : Gamma Knife Radiosurgery for Metastatic Melanoma: An Analysis of Survival, Outcome, and Complications Neurosurgery 44 1999 59-66
10. K. Takakura K. Sano S Hojo et al. Metastatic Tumors of the Central Nervous System 1982 Igaku-Shoin New York
11. M. Sen A.S. Demiral R. Cetingoz et al. Prognostic factors in lung cancer with brain metastasis Radiother Oncol 46 1998 33-38
12. S. Culine M. Bekradda A Kramar et al. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma Cancer 83 1998 2548-2553
13. N.J. Vogelzang W.M. Stadler Kidney cancer Lancet 352 1998 1691-1696
14. H. Nakagawa A. Murasawa S et al. Nakajima Study of meningeal carcinomatosis: Diagnosis and treatment Neurol Surg 20 1992 31-37
15. F.J. Lagerwaard P.C. Levendag P.J.C.M Nowak et al. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients Int J Radiat Oncol Biol Phys 43 1999 795-803
16. F. Graus R.W. Walker J.C. Allen Brain metastases in children J Pediatr 103 1983 558-561
17. R.A. Patchell J.B. Posner Neurologic complications of systemic cancer Neurol Clin 3 1985 729-750
18. G. Sze C. Johnson Y Kawamura et al. Comparison of single- and triple-dose contrast material in the MR screening of brain metastases JNR Am J Neuroradiol 19 1998 821-828
19. D.A. Decker V.L. Decker A. Herskovic G.D. Cummings Brain metastases in patients with renal cell carcinoma: Prognosis and treatment J Clin Oncol 2 1984 169-173
20. J. Posner N. Chernik Intracranial metastases from systemic cancer Adv Neurol 19 1978 579-592
21. G. Riethmuller C.A. Klein Early cancer cell dissemination and late metastatic relapse: Clinical reflections and biological approaches to the dormancy problem in patients Semin Cancer Biol 11 2001 307-311
22. E.C. Kauffman V.L. Robinson W.M Stadler et al. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site J Urol 169 2003 1122-1133
23. A.F. Chambers I.C. MacDonald E.E Schmidt et al. Clinical targets for anti-metastasis therapy Adv Cancer Res 79 2000 91-9121
24. J.H. Morse J.G. Turcotte R.M Merion et al. Development of a malignant tumor in a liver transplant graft procured form a donor with a cerebral neoplasm Transplantation 50 1990 875-877
25. J.C. Ruiz J.G. Cotorruelo V Tudela et al. Transmission of glioblastoma multiforme to two kidney transplant recipients from the same donor in the absence of ventricular shunt Transplantation 55 1993 682-683
26. F. Val-Bernal J.C. Ruiz J.G. Cotorruelo M. Arias Glioblastoma multiforme of donor origin after renal transplantation: Report of a case Hum Pathol 24 1993 1256-1259
27. L. Weiss E. Grundmann J Torhorst Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsies J Pathol 150 1986 195-203
28. J.Y. Delattre G. Krol H.T. Thaler J.B. Posner Distribution of brain metastases Arch Neurol 45 1988 741-744
29. H. Hasegawa Y. Ushio T Hayakawa et al. Changes of the blood-brain barrier in experimental metastatic brain tumors J Neurosurg 59 1983 304-310
30. D. Long Capillary ultrastructure in human metastatic brain tumors J Neurosurg 51 1983 53-58
31. B.A. Yoshida M.M. Sokoloff D.R. Welch C.W. RinkerSchaeffer Metastasis-suppressor genes: A review and perspective on an emerging field J Natl Cancer Inst 92 2000 1717-1730
32. T.H. Kuo T. Kubota M Watanabe et al. Liver colonization competence governs colon cancer metastasis Proc Natl Acad Sci USA 92 1995 12085-12089
33. G.L. Nicolson Cancer metastasis: Tumor cell and host organ properties important in metastasis to specific secondary sites Biochim Biophys Acta 948 2 1988 175-224
34. M. Chackal-Roy C. Niemeyer M. Moore R.R. Zetter Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow J Clin Invest 84 1989 43-50
35. C.J. Aslakson J.W. Rak B.E. Miller F.R. Miller Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis Int J Cancer 47 3 1991 466-472
36. A. Leone U. Flatow C.R King et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells Cell 65 1991 25-35
37. J.T. Dong P.W. Lamb C.W Rinker-Schaeffer et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 Science 268 1995 884-886
38. J.H. Lee M.E. Miele D.J Hicks et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene J Natl Cancer Inst 88 23 1996 1731-1737
39. A.C. Gao W. Lou J.T. Dong J.T. Isaacs CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13 Cancer Res 57 1997 846-849
40. B.A. Yoshida Z. Dubauskas M.A Chekmareva et al. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17 Cancer Res 59 1999 5483-5487
41. Z.M. Bhujwalla E.O. Aboagye R.J Gillies et al. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A 31P nuclear magnetic resonance study in vivo and in vitro Magn Reson Med 41 1999 897-903
42. M.J. Seraj R.S. Samant M.F. Verderame D.R. Welch Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13 Cancer Res 60 2000 2764-2769
43. V.L. Morris E.E. Schmidt S Koop et al. Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis Exp Cell Res 219 1995 571-578
44. M.H. Herynk R. Radinsky The coordinated functional expression of epidermal growth factor receptor and c-Met in colorectal carcinoma metastasis In Vivo 14 2000 587-596
45. A.M. De Marzo B. Knudsen K. Chan-Tack J.I. Epstein E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens Urology 53 1999 707-713
46. S.H. Choi K. Takahashi H Eto et al. CD44s expression in human colon carcinomas influences growth of liver metastases Int J Cancer 85 2000 523-526
47. B.V. Kallakury C.E. Sheehan R.A Ambros et al. Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas J Clin Oncol 16 1998 1302-1309
48. M.A. Noordzij G.J. van Steenbrugge F.H. Schroder T.H. Van der Kwast Decreased expression of CD44 in metastatic prostate cancer Int J Cancer 84 1999 478-483
49. A.C. Gao W. Lou J.P. Sleeman J.T. Isaacs Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate Cancer Res 58 1998 2350-2352
50. K. Tozawa Y. Yamada N Kawai et al. Osteopontin expression in prostate cancer and benign prostatic hyperplasia Urol Int 62 1999 155-158
51. K.B. Reddy S.M. Nabha N. Atanaskova Role of MAP kinase in tumor progression and invasion Cancer Metastasis Rev 22 2003 395-403
52. M.A. Chekmareva M.M. Kadkhodaian C.M Hollowell et al. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases Cancer Res 58 1998 4963-4969
53. H.L. Kim D.J. Vander Griend X Yang et al. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers Cancer Res 61 2833-2837
54. H. Yaguchi N. Ohkura T. Tsukada K. Yamaguchi Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23 J Biol Chem 277 2002 38197-38204
55. J. Du G.J. Hannon The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1 Nucleic Acids Res 30 2002 5465-5475
56. Y.H. Tseng D. Vicent J Zhu et al. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23 Cancer Res 61 2001 2071-2079
57. D. Lombardi E. Palescandolo A. Giordano M.G. Paggi Interplay between the antimetastatic nm23 and the retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC12 cells Cell Death Differ 8 2001 470-476
58. D. Ma Z. Xing B Liu et al. NM23-H1 and NM23-H2 repress transcriptional activities of nuclease-hypersensitive elements in the platelet-derived growth factor-A promoter J Biol Chem 277 2002 1560-1567
59. H.N. Fournier C. Albiges-Rizo M.R. Block New insights into Nm23 control of cell adhesion and migration J Bioenerg Biomembr 35 2003 81-87
60. J.F. Harms D.R. Welch M.E. Miele KISS1 metastasis suppression and emergent pathways [review] Clin Exp Metastasis 20 2003 11-18
61. R.S. Samant M.J. Seraj M.M Saunders et al. Analysis of mechanisms underlying BRMS1 suppression of metastasis Clin Exp Metastasis 18 2000 683-693
62. R.A. Patchell Brain metastases Neurol Clin 9 1991 817-824
63. D.S. Russell L.J. Rubinstein Pathology of Tumours of the Nervous System 5th ed 1989 Edward Arnold London 825-54
64. S.H. Nutt R.A. Patchell Intracranial hemorrhage associated with primary and secondary tumors Neurosurg Clin N Am 3 1992 591-599
65. B.R. DeYoung M.R. Wick Immunohistologic evaluation of metastatic carcinomas of unknown origin: An algorithmic approach Semin Diagn Pathol 17 2000 184-193
66. O. Nappi S.E. Mills P.E. Swanson M.R. Wick Clear cell tumors of unknown nature and origin: A systematic approach to diagnosis Semin Diagn Pathol 14 1997 164-174
67. R.J. Motzer E. Rodriguez V.E Reuter et al. Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies J Natl Cancer Inst 83 1991 341-346
68. D.H. Ilson R.J. Motzer E Rodriguez et al. Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site Semin Oncol 20 1993 229-237
69. S.P. Wilczynski Molecular biology In: N. Weidner R.J. Cote S. Suster L.M. Weiss editors, Modern Surgical Pathology 2003 Saunders Philadelphia 90-9127
70. Cairncross JG, Posner JB. The management of brain metastases. In: Walker MD, editor. Oncology of the Nervous System. Cancer Treatment and Research, Vol 12. Boston: Martinus Nijhoff; 1983. p. 341-77.
71. F.R. Hendrickson The optimum schedule for palliative radiotherapy for metastatic brain cancer Int J Radiat Oncol Biol Phys 2 1977 165-168
72. A.B. Lassman L.M. DeAngelis Brain metastases Neurol Clin N Am 21 2003 1-23
73. R. Soffietti R. Ruda R. Mutani Management of brain metastases J Neurol 249 2002 1357-1369
74. A.J. Tikhtman R.A. Patchell Brain metastases In: R.A. Morantz J.W. Walsh editors. Brain Tumors: A Comprehensive Text 1994 Marcel Dekker New York 533-566
75. M.D. Simionescu Metastatic tumors of the brain: A follow-up study of 195 patients with neurosurgical considerations J Neurosurg 17 1960 361-373
76. P.A. Forsythe J.B. Posner Headaches in patients with brain tumors: A study of 111 patients Neurology 43 1993 1678-1683
77. J.B. Posner Clinical manifestations of brain metastasis. In: L. Weiss H. Gilbert J. Posner (Eds.) Brain Metastasis 1980 GK Hall & Co Boston 189-207
78. M. Salcman Intracranial hemorrhage caused by brain tumors. In: H. Kaufman (Ed.) Intracerebral Hematomas 1992 Raven Press New York 95-9106
79. M.J. Glantz B.F. Cole P.A Forsyth et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54 2000 1886-1893
80. M.P. Merchut Brain metastases from undiagnosed systemic neoplasms Arch Intern Med 149 1989 1076-1080
81. R. Sawaya R.K. Bindal Metastatic brian tumors In: A.H. Kaye E.R. Laws Jr editors. Brain Tumors: An Encyclopedic Approach 1995 Churchhill Livingstone Edinburgh 923-946
82. M. Van de Pol V.C. van Aalst J.T. Wilmink A. Twijnstra Brain metastases from an unknown primary tumor: Which diagnostic procedures are indicated? J Neurol Neurosurg Psychiatry 61 1996 321-323
83. A.C. Kole O.E. Niewig J Pruim et al. Detection of unknown primary tumors using positron emission tomography Cancer 82 1998 1160-1166
84. R. Ruda M. Borgognone F Benech Brain metastases from unknown primary tumor: A prospective study J Neurol 248 2001 394-398
85. M.E. Healy J.R. Hesselink Increased detection of intracranial metastases with intravenous Gd-DTPA Radiology 165 1987 619-624
86. D. Bell R. Grant D Collie How well do radiologists diagnose intracerebral tumour histology on CT? Findings from a prospective multicentre study. Br J Neurosurg 16 2002 573-577
87. F.F. Lang R. Sawaya Surgical management of cerebral metastases Neurosurg Clin North Am 7 1996 459-484
88. F.F. Lang R. Sawaya Surgical treatment of metastatic brain tumors Semin Surg Oncol 14 1998 53-63
89. S.T. Chao J.H. Suh S Raja The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery Int J Cancer. 96 2001 191-197
90. D. Galanaud F. Nicoli Y Le Fur et al. [Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors.] Ann Med Interne (Paris) 153 2002 491-498
91. J. Sabatier D. Ibarrola M. Malet-Martino I. Berry [Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis.] Rev Neurol (Paris) 157 8-9 Pt 1 2001 858-862
92. R.P. Moser M.L. Johnson Surgical management of brain metastases: How aggressive should we be? Oncology 3 1989 123-128
93. A. Muacevic F.W. Kreth G.A Horstmann et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter J Neurosurg 91 1999 35-43
94. C.J. Vecht H. Haaxma-Reiche E.M Noordijk et al. Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery? Ann Neurol 33 1993 583-590
95. R.A. Patchell P.A. Tibbs J.W Walsh et al. A randomized trial of surgery in the treatment of single metastases to the brain N Engl J Med 322 1990 494-500
96. A.H. Mintz J. Kestle M.P Rathbone et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis Cancer 78 1996 1470-1476
97. D.J. Magilligan Jr C. Duvernoy G Malik et al. Surgical approach to lung cancer with solitary cerebral metastasis: Twenty-five years' experience Ann Thorac Surg 42 1986 360-364
98. J.R. Hankins J.E. Miller M Salcman et al. Surgical management of lung cancer with solitary cerebral metastasis Ann Thorac Surg 46 1988 24-28
99. S.R. Smalley E.R. Laws Jr J.R O'Fallon et al. Resection for solitary brain metastasis: Role of adjuvant radiation and prognostic variables in 229 patients J Neurosurg 77 1992 531-540
100. M. Wronski E. Arbit M. Burt J.H. Galicich Survival after surgical treatment of brain metastases from lung cancer: A follow-up study of 231 patients treated between 1976 and 1991 J Neurosurg 83 995 605-616
101. J.C. Bendell S.M. Domchek H.J Burstein et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma Cancer 97 2003 2972-2977
102. J.C. Buchsbaum J.H. Suh S.Y Lee et al. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: A retrospective study Cancer 94 2002 2265-2272
103. I.W. Tremont-Lukats G. Bobustuc G.K Lagos et al. Brain metastasis from prostate carcinoma: The M.D Anderson Cancer Center experience Cancer 98 2003 363-368
104. I.E. McCutcheon D.Y. Eng C.J. Logothetis Brain metastasis from prostate carcinoma: Antemortem recognition and outcome after treatment Cancer 86 1999 2301-2311
105. G. Cormio A. Maneo A Colamaria et al. Surgical resection of solitary brain metastasis from ovarian carcinoma: An analysis of 22 cases Gynecol Oncol 89 2003 116-119
106. D. Tajran J.S. Berek Surgical resection of solitary brain metastasis from cervical cancer Int J Gynecol Cancer 13 2003 368-370
107. A.N. Mamelak G.J. Withers X. Wang Choriocarcinoma brain metastasis in a patient with viable intrauterine pregnancy: Case report J Neurosurg 97 2002 477-481
108. F.C. Ko J.M. Liu W.S Chen et al. Risk and patterns of brain metastases in colorectal cancer: 27-year experience Dis Colon Rectum 42 1999 1467-1471
109. M.A. Hammoud I.E. McCutcheon R Elsouki et al. Colorectal carcinoma and brain metastasis: Distribution, treatment, and survival Ann Surg Oncol 3 1996 453-463
110. G.F. Farnell J.C. Buckner T.L Cascino et al. Brain metastases from colorectal carcinoma: The long term survivors Cancer 78 1996 711-716
111. ronski M, Arbit E. Cancer. Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 1999;85:1677-85.
112. H. Sueyama T. Yamanoi T Uematu et al. [Brain metastases from esophageal cancers: Clinical features and treatment results] Nippon Igaku Hoshasen Gakkai Zasshi 61 2001 534-539
113. J.E. York J. Stringer J.A Ajani et al. Gastric cancer and metastasis to the prain Ann Surg Oncol 6 1999 771-776
114. J. Ransohoff Surgical management of metastatic tumors Semin Oncol 2 1975 21-27
115. R.A. Patchell Metastatic brain tumors Neurol Clin 13 1995 915-925
116. R.K. Bindal R. Sawaya M.E. Leavens J.J. Lee Surgical treatment of multiple brain metastases J Neurosurg 79 1993 210-216
117. P. Davis P. Hudgins S. Peterman J.J. Hoffman Diagnosis of cerebral metastases: Double-dose delayed CT vs contrast-enhanced MR imaging AJNR 12 1991 293-300
118. G. Sze E. Milano C. Johnson L. Heier Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT AJNR 11 1990 785-791
119. E.S. Nussbaum H.R. Djalilian K.H. Cho W.A. Hall Brain metastases: histology, multiplicity, surgery, and survival Cancer 78 1996 1781-1788
120. S. Madajewicz S. Karakousis C West et al. Malignant melanoma brain metastases: Review of Roswell Park Memorial Institute experience Cancer 53 1984 2550-2552
121. T. Byrne T. Cascino J. Posner Brain metastases from melanoma J Neurooncol 1 1983
122. M.M. Konstadoulakis E. Messaris G Zografos et al. Prognostic factors in malignant melanoma patients with solitary or multiple brain metastases: is there a role for surgery? J Neurosurg Sci 44 2000
123. Y. Iwadate H. Namba A. Yamaura Significance of surgical resection for the treatment of multiple brain metastases Anticancer Res 20 2000
124. J.M. Kurtz R. Gelber L.W Brady The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 7 1981 891-895
125. B. Borgelt R. Gelber S Kramer et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 6 1980 1-9
126. K.J. Murray C. Scott H.M Greenberg et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104 Int J Radiat Oncol Biol Phys 39 1997 571-574
127. L.T. Komarnicky T.L. Phillips K Martz et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916) Int J Radiat Oncol Biol Phys 20 1991 53-58
128. L. Gaspar C. Scott M. Rotman et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 1997 745-751
129. P.S. Swift T. Phillips K Martz et al. CT characteristics of patients with brain metastases treated in RTOG study 79-16 Int J Radiat Oncol Biol Phys 25 1993 209-214
130. K.K. Fu T.F. Pajak A Trotti et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7-16
131. B.E. Epstein C.B. Scott W.T Sause et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater: Results of Radiation Therapy Oncology Group 85-28 Cancer 71 1993 1362-1367
132. R.A. Patchell P.A. Tibbs W.F Regine et al. Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial JAMA 280 1998 1485-1489
133. L.M. DeAngelis J.Y. Delattre J.B. Posner Radiation-induced demetia in patients cured of brain metastases Neurology 39 1989 789-796
134. A. Auperin R. Arriagada J.P Pignon et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission: Prophylactic Cranial Irradiation Overview Collaborative Group N Engl J Med 341 1999 476-484
135. J.A. Bonner J. Sloan S Hillman et al. A phase II study of high dose twice-daily thoraic radiation therapy with concomitant cisplatin/etoposide in limited stage small cell lung cancer Proc ASCO 20 2001 316a (abs)
136. V.W. Rusch B.R. Griffin R.B. Livingston The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer: A Southwest Oncology Group Study J Thorac Cardiovasc Surg 98 1989 535-539
137. T.L. Phillips C.B. Scott S.A Leibel et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: Report of RTOG trial 89-05 Int J Radiat Oncol Biol Phys 33 1995 339-348
138. M.P. Mehta P. Rodrigus C.H Terhaard et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases J Clin Oncol 21 2003 2529-2536
139. L.E. Abrey C. Christodoulou Temozolomide for treating brain metastases Semin Oncol 28 2001
140. D. Antonadou N. Coliarakis M. Paraskevaidis et al. Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study Int J Radiat Oncol Biol Phys 54(suppl.) 2002 93-94 (abs)
141. G.T. Szeifert N. Massager D DeVriendt et al. Observations of intracranial neoplasms treated with gamma knife radiosurgery J Neurosurg 97 2002 623-626
142. S.N. Sanghavi S.S. Miranpuri R et al. Chappell Radiosurgery for patients with brain metastases: A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method Int J Radiat Oncol Biol Phys 51 2001 426-434
143. R.M. Auchter J.P. Lamond E Alexander et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for respectable single brain metastasis Int J Radiat Oncol Biol Phys 35 1996 27-35
144. D. Kondziolka A. Patel L.D Lunsford et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases Int J Radiat Oncol Biol Phys 45 1999 427-434
145. P.W. Sperduto C. Scott D Andrews et al. Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: Report of Radiation Therapy Oncology Group Phase III Study 95-08 Int J Radiat Oncol Biol Phys 54(suppl.) 2002 3
146. E. Shaw C. Scott L Souhami et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05 Int J Radiat Oncol Biol Phys 47 2000 291-298
147. V. Sturm B. Kober K.H Hover et al. Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator Int J Radiat Oncol Biol Phys 13 1987 279-282
148. J.S. Loeffler H.M. Kooy P.Y Wen et al. The treatment of recurrent brain metastases with stereotactic radiosurgery J Clin Oncol 8 1990 571-573
149. R.J. Coffey J.C. Flickinger D.J. Bissonette L.D. Lunsford Radiosurgery for solitary brain metastases using the cobalt-60 gamma unit: Methods and results in 24 patients Int J Radiat Oncol Biol Phys 20 1991 1287-1295
150. M.P. Mehta J.M. Rozental A.B Levin et al. Defining the role of radiosurgery in the management of brain metastases Int J Radiat Oncol Biol Phys 24 1992 619-625
151. J.C. Flickinger D. Kondziolka L.D Lunsford et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis Int J Radiat Oncol Biol Phys 28 1994 797-802
152. A. Asai M. Matsutani T Kohno et al. Subacute brain atrophy after radiation therapy for malignant brain tumor Cancer 63 1989 1962-1974
153. W.F. Regine J.L. Huhn R.A Patchell et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: Results and implications Int J Radiat Oncol Biol Phys 52 2002 333-338
154. W.F. Regine C. Scott K. Murray W. Curran Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: An analysis from radiation therapy oncology group study 91-04 Int J Radiat Oncol Biol Phys 51 2001 711-717
155. T. Hasegawa D. Kondziolka J.C Flickinger et al. Brain metastases treated with radiosurgery alone: An alternative to whole brain radiotherapy Neurosurgery 52 2003 1318-1326
156. C. Nieder U. Nestle B Motaref et al. Prognostic factors in brain metastases: Should patients be selected for aggressive treatment accorning to recursive partitioning analysis (RPA) classes? Radiat Oncol 46 2000 297-302
157. M.A. Chidel J.H. Suh C.A Reddy et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients with stereotactic radiosurgery for newly diagnosed brain metastases Radiat Oncol 47 2000 993-997
158. P.K. Sneed K.R. Lamborn J.M Forstner et al. Radiosurgery for brain metastases: Is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43 1999 549-558
159. J. Lutterbach D. Cyron K. Henne C.B. Ostertag Radiosurgery followed by planned observation in patients with one to three brain metastases Neurosurgery 52 2003 1066-1073
160. I. Chitapanarux B. Goss R Vongama et al. Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: Incidence of intracranial progression and salvage radiotherapy J Neurooncol 61 2003 143-149
161. P.K. Sneed J.H. Suh S.J Goetsch et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases Int J Radiat Oncol Biol Phys 53 2002 519-526
162. A. Pirzkall J. Debus F Lohr et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases J Clin Oncol 16 1998 3563-3569
163. B.P. O'Neill N.J. Iturria M.J Link et al. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases Int J Radiat Oncol Biol Phys 55 2003 1169-1176
164. A.K. Bindal R.K. Bindal K.R Hess et al.Surgery versus radiosurgery in the treatment of brain metastasis J Neurosurg 84 1996 748-754
165. M. Mehta W. Noyes B Craig et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs resection fro single brain metastases. Int J Radiat Oncol Biol Phys 39 1997 445-454
166. G. Bauman P. Pahapill D. Macdonald B. Fisher C. Leighton G. Cairncross Low grade glicoma: A measuring radiographic response to radiotherapy Can J Neurol Sci 26 1999 18-22
167. F. Grossi T. Scolaro L Tixi et al. The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer Crit Rev Oncol Hematol 37 2001 61-67
168. P.E. Postmus E.F. Smit Chemotherapy for brain metastases of lung cancer: a review Ann Oncol 10 1999 753-759
169. C.J. Twelves R.L. Souhami Should cerebral metastases be treated by chemotherapy alone? Ann Oncol 2 1991 15-17
170. G. Landonio A. Sartore-Bianchi L Giannetta et al. Controversies in the management of brain metastases: The role of chemotherapy Forum 11 2001 59-74
171. R. Dziadziuszko A. Ardizzoni P.E Postmus et al. Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases: A phase II study of the EORTC Lung Cancer Group (08965) Eur J Cancer 39 9 2003 1271-1276
172. Y. Ushio N. Arita T Hayakawa et al. Chemotherapy of brain metastases from lung carcinoma: A controlled randomized study Neurosurgery 28 2 1991 201-205
173. F. Cappuzzo C. Calandri S. Bartolini L. Crino ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): Report of four cases Br J Cancer 89 2003 246-247
174. D. Schiff P.Y. Wen Cancer Neurology in Clinical Practice 2002 Humana Press Totowa
175. V. Franciosi G. Cocconi M Michiara et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: A prospective study Cancer 85 1999 1599-1605
176. D. Antonadou M. Paraskevaidis G Sarris et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 20 2002 3644-3650
177. H.B. Newton M.A. Slivka C Volpi et al. Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors J Neurooncol 61 2003 35-44
178. M. Gerosa A. Nicolato R Foroni et al. Gamma knife radiosurgery for brain metastases: A primary therapeutic option J Neurosurg 97 Suppl 5 2002 515-524
179. J.B. Stubbs A.D. Strickland R.K Frank et al. Biodistribution and dosimetry of an aqueous solution containing sodium 3-(125I)iodo-4-hydroxybenzenesulfonate (Iotrex) for brachytherapy of resected malignant brain tumors Cancer Biother Radiopharm 15 2000 645-656
180. M.W. McDermott G.R. Cosgrove D.A Larson et al. Interstitial brachytherapy for intracranial metastases Neurosurg Clin N Am 7 1996 485-495
181. H. Brem S. Piantadosi P.C Burger et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas: The Polymer-brain Tumor Treatment Group Lancet 345 1995 1008-1012
182. M.G. Ewend P. Sampath J.A Williams et al. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma Neurosurgery 43 1998 1185-1193
183. M.G. Ewend J.A. Williams K Tabassi et al. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models Cancer Res 56 1996 5217-5223
184. Brem S, Snodgrass S, Staller A, et al. Implantation of BCNU Chemotherapeutic Wafers to Prevent Recurrence of Brain Metastases [poster]. Presented at AANS 2003 Annual Meeting. April 26-May 1, 2003, San Diego, CA.
185. C.L. Arteaga The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia J Clin Oncol 19 suppl. 2001 32s-40s
186. S. Scholl P. Beuzeboc P. Pouillart Targeting HER2 in other tumor types Ann Oncol 12 Suppl 1 2001 S81-S87
187. E.S. Kim F.R. Khuri R.S. Herbst Epidermal growth factor receptor biology (IMC-C255) Curr Opin Oncol 13 2001 506-513
188. S. Kunwar L.H. Pai I. Pastan Cytotoxicity and antitumor effects of growth-factor-toxin fusion proteins on human glioblastoma multiforme cells J Neurosurg 79 1993 569-576
189. J. Baselga Targeting the epidermal growth factor receptor: A clinical reality J Clin Oncol 19(suppl.) 2001 41s-44s
190. F. Cappuzzo A. Ardizzoni H Soto-Parra et al. Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC) Lung Cancer 41 2003 227-231
191. J. Zujewski I.D. Horak C.J Bol et al. Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer J Clin Oncol 18 2000 927-941
192. Dannenberg AJ, Altorki NK, Subbaramaiah K. Selective inhibitors of COX-2: New applications in oncology. Proc Am Soc Clin Oncol Educ Bk Alexandria, VA 2001;21-27.
193. F.A. Scappaticci Mechanisms and future directions for angiogenesis-based cancer therapies J Clin Oncol 20 2002 3906-3927
194. M. Hildago S.G. Eckhardt Development of matrix metalloproteinase inhibitors in cancer therapy J Natl Cancer Inst 93 2001 178-193
195. J.B. Posner Diagnosis and treatment of metastases to the brain Clin Bull 4 1974 47-57
196. M.P. Mehta W.R. Shapiro M.J Glantz et al. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: Centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points J Clin Oncol 20 20023445-3453
197. B.O. Hutter U. Spetzger H. Bertalanffy J.M. Gilsbach Cognition and quality of life in patients after transcallosal microsurgery for midline tumors J Neurosurg Sci 41 1997 123-129
198. N.K. Aaronson S. Ahmedzai B Bergman et al. The European organization for research and treatment of cancer QLQ-C30: A quality of life instrument for use in international trials in oncology J Natl Cancer Inst 85 1993 365-376
199. S. Sehlen H. Hollenhorst B Schymura Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy Onkologie 26 2003 38-43
200. M.P. Lovely Quality of life of brain tumor patients Semin Oncol Nurs 14 1998 73-80
201. D. Osoba M. Brada M.D. Prados W.K. Yung Effect of disease burden on health-related quality of life in patients wiht malignant gliomas NeuroOncology 2 2000 221-228
202. C.A. Meyers Quality of life of brain tumor patients. In: M. Bernstein M.S. Berger (Eds.) Neuro-Oncology: The essentials 2000 Thieme Medical Publishers New York 466-472
203. S. Hoshi H. Jokura H Nakamura et al. Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: Results in 42 patients Int J Urol 9 2002 618-627
204. T.S. Vesagas J.A. Aguilar E.R. Mercado M.M. Mariano Gamma knife radiosurgery and brain metastases: Local control, survival, and quality of life J Neurosurg 97 5 Suppl. 2002 507-510
205. N. Mackworth P. Fobair M. Prados Quality of life self-reports from 200 patients: Comparisons with Karnofsky Performance Scale J Neurooncol 14 1992 243-253
206. T. Morita J. Tsunoda S. Inoue S. Chihara Contributing factors to physical symptoms in terminally-ill cancer patients J Pain Symptom Manage 18 1999 338-346
207. D. Osoba M. Brada W.K. Yung M. Prados Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme J Clin Oncol 18 2000 1481-1491
208. A.C. Whitton H. Rhydderch W. Furlong D. Feeny R.D. Barr Self-reported comprehensive health status of adult brain tumor patients using the Health Utilities Index [comment] Cancer 80 1997 258-265
209. K.M. Foley H. Gelband Improving Palliative Care for Cancer 2001 National Cancer Policy Board, Institute of Medicine and National Research Council Washington, DC p. 64
210. D. Spiegel Cancer and depression Br J Psychiatry 30 Suppl. 1996 106-109
211. M.D. Lezak Neuropsychological Assessment 1995 Oxford University Press New York 650-85
212. E. Irle M. Peper B. Wowra S. Kunze Mood changes after surgery for tumors of the cerebral cortex Arch Neurol 51 1994 164-174
213. H. Hecaen Clinical symptomatology in right and left hemisphere lesions. In: V.B. Mountcastle (Ed.) Interhemispheric Relations and Cerebral Dominance in Man 1962 Johns Hopkins University Press Baltimore
214. K.M. Heilman D. Bowers E. Valenstein Emotional disorders associated with neurological diseases. In: K.M. Heilman E. Valenstein (Eds.) Clinical Neuropsychology 1993 Oxford University Press New York
215. B.H. Price M. Mesulam Psychiatric manifestations of right hemisphere infarctions J Nerv Ment Dis 173 1985 610-614
216. J.I. Mechanick F.H. Hochberg A. LaRocque Hypothalamic dysfunction following whole-brain irradiation J Neurosurg 65 1986 490-494
217. A.A. Patkar K.P. Hill S.P. Weinstein S.L. Schwartz ECT in the presence of brain tumor and increased intracranial pressure: Evaluation and reduction of risk J ECT 16 2000 189-197
218. D. Dressler J. Folk The treatment of depression with ECT in the presence of brain tumor Am J Psychiatry 132 1975 1320-1321
219. C.A. Meyers K.R. Hess W.K. Yung V.A. Levin Cognitive function as a predictor of survival in patients with recurrent malignant glioma J Clin Oncol 18 2000 646-650
220. Farace E, Turkheimer E, Wilkniss S. Utility of Analyzing Lesion Location in an Outcome Study of Traumatic Brain Injury. Presented at the International Neuropsychological Society, Seattle, WA, February 9, 1995.
221. R.S. Scheibel C.A. Meyers V.A. Levin Cognitive dysfunction following surgery for intracerebral glioma: Influence of histopathology, lesion location, and treatment J Neurooncol 30 1996 61-69
222. D.Y. Gelblum H. Lee M Bilsky Radiographic findings and morbidity in patients treated with stereotactic radiosurgery Int J Radiat Oncol Biol Phys 42 1998 391-395
223. Cummings J. In: Cummings J, editor. Introduction in Subcortical Dementia. New York:OXford University Press; 1990. p. 3-16.
224. G.C. Roman T.K. Tatemichi T Erkinjuntti et al. Vascular dementia: diagnostic criteria for research studies Report of the NINDS-AIREN International Workshop. Neurology 43 1993 250-260
225. M.A. Herman I. Tremont-Lukats C.A Meyers et al. Neurocognitive and functional assessment of patients with brain metastases: A pilot study Am J Clin Oncol 26 2003 273-279
226. S.J. DiBiase L.S. Chin L. Ma Influence of gamma knife radiosurgery on the quality of life in patients with brain metastases Am J Clin Oncol 25 2002 131-134
227. S.S. Vermeulen Whole brain radiotherapy in the treatment of metastatic brain tumors Semin Surg Oncol 14 1998 64-69
228. T.A. Ahles P.M. Silberfarb J. Herndon 2nd et al. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukemia Group B J Clin Oncol 16 1998 1954-1960
229. J. Kelaghan M.H. Myers J.J Mulvihill et al. Educational achievement in long-term survivors of childhood and adolescent cancer Med Pediatr Oncol 16 1998 320-326
230. M.D. Ris R.B. Noll Long-term neurobehavioral outcome in pediatric brain-tumor patients: Review and methodological critique J Clin Exp Neuropsychol 16 1994 21-42
231. R.J. Packer L.N. Sutton T.E Atkins et al. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results J Neurosurg 70 1989 707-713
232. M. Dennis B.J. Spiegler H.J Hoffman et al. Brain tumors in children and adolescents-I: Effects on working, associative and serial-order memory of IQ, age at tumor onset, and age of tumor Neuropsychologia 29 1991 813-827
233. D.L. Johnson M.A. McCabe H.S Nicholson et al. Quality of long-term survival in young children with medulloblastoma J Neurosurg 80 1994 1004-1010
234. D. Jenkin C. Canjoux M. Greenberg Subsequent quality of life for children irradiated for a brain tumor before age four years Med Pediatr Oncol 31 1998 506-511
235. M.J. Taphoorn A.K. Schiphorst F.J Snoek et al. Cognitive functions and quality of life in patients with low-grade gliomas: The impact of radiotherapy Ann Neurol 36 1994 48-54
236. B.V. Taylor J.C. Buckner T.L Cascino et al. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma J Clin Oncol 16 1998 2195-2201
237. P.D. Maguire R. Clough A.H. Friedman E.C. Halperin Fractionated external-beam radiotherapy for meningiomas of the cavernous sinuses Int J Radiat Oncol 44 1999 75-79
238. A.G. Van Oosterhout P.G. Ganzevles J.T Wilmink et al. Sequelae in long-term survivors of small cell lung cancer Int J Radiat Oncol Biol Phys 34 1996 1037-1044
239. M. van de Pol G.P. ten Velde J.T Wilmink et al. Efficacy and safety of prophylactic cranial irradiation in patients with small cell lung cancer J Neurooncol 35 1997 153-160
240. C.A. Meyers C. Boake Neurobehavioral disorders in brain tumor patients: rehabilitation strategies Cancer Bull 45 1993 362 (abs)
241. W.F. Baile Neuropsychiatric disorders in cancer patients Curr Opin Oncol 8 1996 182-187
242. F. Keime-Guibert M. Napolitano J.Y. Delattre Neurological complications of radiotherapy and chemotherapy J Neurol 245 1998 670-695
243. A. Routh T. Khansur B.T. Hickman D. Bass Management of brain metastases: past, present, and future South Med J 87 1994 1218-1226
244. C.J. Vecht A. Hovestadt H.B Verbiest et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: A randomized study of doses of 4, 8, and 16 mg per day Neurology 44 1994 675-680
245. J. Cortes H. Kantarjian S O'Brien Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older Am J Med 100 1996 452-455
246. M.A. Weitzner Psychosocial and neuropsychiatric aspects of patients with primary brain tumors Cancer Invest 17 1999 285-297
247. G. Pelletier M.J. Verhoef N. Khatri N. Hagen Quality of life in brain tumor patients: The relative contributions of depression, fatigue, emotional distress, and existential issues J Neurooncol 57 2002 41-49
248. L.L. Barclay J.P. Blass R.E. Lee Cerebral metastases mimicking depression in a "forgetful" attorney J Am Geriatr Soc 32 1984 866-867
249. S.I. Anderson R. Taylor I.R. Whittle Mood disorders in patients after treatment for primary intracranial tumours Br J Neurosurg 13 1999 480-485
250. M.M. Ziemer Effects of information on postsurgical coping Nurs Res 32 1983 282-287
251. G. Gainotti G. Antonucci C. Marra S. Paolucci Relation between depression after stroke, antidepressant therapy, and functional recovery J Neurol Neurosurg Psychiatry 71 2001 258-261
252. A. Berg H. Palomaki M Lehtihalmes et al. Poststroke depression in acute phase after stroke Cerebrovasc Dis 12 2001 14-20
253. A.M. Nezu C.M. Nezu Clinical Decision Making in Behavior Therapy: A Problem-Solving Perspective 1989 Research Press Champaign, IL
254. A.M. Nezu C.M. Nezu S.H. Friedman S. Faddis P.S. Houts Helping Cancer Patients Cope: A Problem Solving Approach 1998 American Psychological Association Washington, DC
255. S.K. Lutgendorf B. Anderson P Ullrich et al. Quality of life and mood in women with gynecologic cancer: A one year prospective study Cancer 94 2002 131-140
256. L. Cohen C. de Moor R.J. Amato The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a phase I cancer clinical trial Cancer 91 2001 1949-1955
257. F. Baker B. Curbow J.R. Wingard Role retention and quality of life of bone marrow transplant survivors Soc Sci Med 32 1991 697-704
258. S.M. Allen A.C. Shah A.M Nezu et al. A problem-solving approach to stress reduction among younger women with breast carcinoma: A randomized controlled trial Cancer 94 2002 3089-3100
259. F.H. Hochberg B. Slotnick Neuropsychologic impairment in astrocytoma survivors Neurology 30 1980 172-177
260. E.R. Laws The decade of the brain: 1990-2000 Neurosurgery 47 2000 1257-1260
261. Laws E, Shaffrey M. Surgical management of intracranial gliomas-biopsy resection or watchful waiting. Clin Neurosurg 2001;48:37-45.
262. BTPRG, Report of the Brain Tumor Progress Review Group (BTPRG). National Institutes of Health; http://www.ninds.nih.gov/about_ninds/btprg/btprgreport.htm 2000.